Eagle Pharmaceuticals, Inc. Proceeds from Issuance Initial Public Offering
Eagle Pharmaceuticals, Inc. reported Proceeds from Issuance Initial Public Offering of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2017-03-15
- Eagle Pharmaceuticals, Inc. proceeds from issuance initial public offering for the quarter ending 2014-12-31 was $0.00.
- Eagle Pharmaceuticals, Inc. proceeds from issuance initial public offering for fiscal 2016 was $0.00.
- Eagle Pharmaceuticals, Inc. proceeds from issuance initial public offering for fiscal 2015 was $0.00.
- Eagle Pharmaceuticals, Inc. proceeds from issuance initial public offering for fiscal 2014 was $46.07M.
- Eagle Pharmaceuticals, Inc. proceeds from issuance initial public offering for fiscal 2013 was $0.00.
| Period end | Proceeds from Issuance Initial Public Offering | Proceeds from Issuance Initial Public Offering 1 month | Proceeds from Issuance Initial Public Offering 1 month as first filed | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-15 | ||||
| 2015-12-31 | $0.00 10-K · filed 2017-03-15 | ||||
| 2014-12-31 | $0.00 10-K · filed 2017-03-15 | ||||
| 2014-09-30 | $46.07M 10-K · filed 2017-03-15 | ||||
| 2014-03-18 | $46.07M 10-K · filed 2017-03-15 | ||||
| 2014-02-18 | $46.07M 10-Q · filed 2015-11-12 | ||||
| 2013-09-30 | $0.00 10-K · filed 2016-02-29 |